article thumbnail

Medicaid expansion is in the eye of the beholder

The Health Policy Exchange

To the ACA's detractors, Medicaid expansion is a hostile government takeover that must be opposed in principle, regardless of potential benefits of an infusion of federal dollars.

Insurance 130
article thumbnail

Direct Primary Care - Role for the Future of Healthcare

The Direct Doctors Difference

Looking back to 2014, when we began, there were less than 100. As the market speaks, the corporations and governments will eventually have to listen. We will see many government and corporate attempts at a Direct-style of practice (many will fail but maybe some will succeed).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biogen agrees to pay $900 million in largest FCA Settlement Ever Secured without Government’s Intervention

FDA Law Blog

Mr. Bawduniak alleged that, between 2009 and 2014, Biogen paid illegal kickbacks to its largest prescribers to induce them to prescribe the company’s multiple sclerosis drugs, Avonex, Tysabri and Tecfidera, and discourage them from prescribing newer competitor products. This lawsuit was brought to the U.S. See United States ex rel.

article thumbnail

From GRP to SIUU – the Evolution of FDA Guidance on Off-Label Dissemination of Scientific Information

FDA Law Blog

Previous iterations of this guidance from 2009 and 2014 (blogged on here and here ) were known as Good Reprint Practices (GRP). The SIUU Guidance, which supersedes the 2014 Draft GRP Guidance, is not substantially different in that regard and contains similar information as to the types of disclosures previously recommended.

Clinic 64
article thumbnail

DSCSA’s Wholesale Drug Distributor and Third-Party Logistics Provider Regulations and Preemption of State Laws: Now Dancing on the “Floor” and the “Ceiling”

FDA Law Blog

Preemption of state laws governing not only the tracking and tracing of prescription drugs but also the licensing of WDDs and 3PLs, is a key component of the DSCSA. 2) State regulation of third-party logistics providers.–No No State shall regulate third-party logistics providers as wholesale distributors.

article thumbnail

FDA Publishes Discussion Paper Seeking Feedback on 3D Printing of Medical Devices at the Point of Care

FDA Law Blog

In October 2014, FDA held a public workshop titled “Additive Manufacturing of Medical Devices: An Interactive Discussion on the Technical Considerations of 3D Printing.” This discussion paper is not the first time that FDA has grappled with the tricky regulatory questions presented by 3D printing. products intended for medical purposes).

Medical 98
article thumbnail

Approaches for Quelling Stigma related to COVID-19

BMJ

Many Chinese expressed their disapproval of the many untrusted sources of information online while demonstrating a high level of trust towards the central government. 2014 (28 August). National involvement is also needed to facilitate these efforts. Front Commun ́2020 (June 12; published online). doi:10.3389/fcomm.2020.00039